David Rubin to United States Food and Drug Administration
This is a "connection" page, showing publications David Rubin has written about United States Food and Drug Administration.
Connection Strength
0.191
-
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development. Clin Gastroenterol Hepatol. 2019 08; 17(9):1673-1679.e1.
Score: 0.136
-
Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review. J Crohns Colitis. 2025 Jul 03; 19(7).
Score: 0.054